021-51111890
购物车（）
sales@molnova.cn
cGMP Dependent Kinase Inhibitor Peptide
CAS No. 82801-73-8
cGMP Dependent Kinase Inhibitor Peptide ( —— )
产品货号. M30676 CAS No. 82801-73-8
Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by PKG. Inhibits phosphorylation of intact histones by PKA.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥6299 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称cGMP Dependent Kinase Inhibitor Peptide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by PKG. Inhibits phosphorylation of intact histones by PKA.
-
产品描述Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by PKG. Inhibits phosphorylation of intact histones by PKA.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number82801-73-8
-
分子量943.12
-
分子式C38H74N18O10
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 100 mg/mL (106.03 mM)
-
SMILES[H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Bhatnagar et al (1988) Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry 27 1988 PMID:
产品手册
关联产品
-
Etifoxine hydrochlor...
依替福辛是一种抗焦虑和抗惊厥化合物。与苯二氮卓类化合物不同，依托替福辛似乎通过与 GABAA 受体复合物的 β2 和 β3 亚基结合来产生抗焦虑作用，因此作用于与苯二氮卓类化合物不同的靶位点，尽管产生的生理作用与苯二氮卓类化合物相似。
-
P61 (343 - 355), M. ...
P61 (343 - 355), M. leprae
-
Pelgifatamab
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.
